Wird geladen...
B-cell reconstitution after lentiviral vector–mediated gene therapy in patients with Wiskott-Aldrich syndrome
BACKGROUND: Wiskott-Aldrich syndrome (WAS) is a severe X-linked immunodeficiency characterized by microthrombocytopenia, eczema, recurrent infections, and susceptibility to autoimmunity and lymphomas. Hematopoietic stem cell transplantation is the treatment of choice; however, administration of WAS...
Gespeichert in:
Veröffentlicht in: | J Allergy Clin Immunol |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
Mosby
2015
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4559137/ https://ncbi.nlm.nih.gov/pubmed/25792466 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2015.01.035 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|